Kanada - angol - Health Canada

sivem pharmaceuticals ulc - sumatriptan (sumatriptan succinate) - tablet - 25mg - sumatriptan (sumatriptan succinate) 25mg - selective serotonin agonists

Kanada - angol - Health Canada

sivem pharmaceuticals ulc - sumatriptan (sumatriptan succinate) - tablet - 50mg - sumatriptan (sumatriptan succinate) 50mg - selective serotonin agonists

Kanada - angol - Health Canada

sivem pharmaceuticals ulc - sumatriptan (sumatriptan succinate) - tablet - 100mg - sumatriptan (sumatriptan succinate) 100mg - selective serotonin agonists

Kanada - angol - Health Canada

pharmascience inc - sumatriptan (sumatriptan succinate) - tablet - 25mg - sumatriptan (sumatriptan succinate) 25mg - selective serotonin agonists

Kanada - angol - Health Canada

pharmascience inc - sumatriptan (sumatriptan succinate) - tablet - 50mg - sumatriptan (sumatriptan succinate) 50mg - selective serotonin agonists

Kanada - angol - Health Canada

pharmascience inc - sumatriptan (sumatriptan succinate) - tablet - 100mg - sumatriptan (sumatriptan succinate) 100mg - selective serotonin agonists

Kanada - angol - Health Canada

actavis pharma company - sumatriptan (sumatriptan succinate) - tablet - 25mg - sumatriptan (sumatriptan succinate) 25mg - selective serotonin agonists

Kanada - angol - Health Canada

actavis pharma company - sumatriptan (sumatriptan succinate) - tablet - 50mg - sumatriptan (sumatriptan succinate) 50mg - selective serotonin agonists

Kanada - angol - Health Canada

teva canada limited - sumatriptan (sumatriptan succinate) - tablet - 100mg - sumatriptan (sumatriptan succinate) 100mg - selective serotonin agonists

Egyesült Államok - angol - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - naratriptan hydrochloride (unii: 10x8x4p12z) (naratriptan - unii:qx3kxl1za2) - naratriptan 1 mg - naratriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. limitations of use: - use only if a clear diagnosis of migraine has been established. if a patient has no response to the first migraine attack treated with naratriptan tablets reconsider the diagnosis of migraine before naratriptan tablets are administered to treat any subsequent attacks. - naratriptan tablets are not indicated for the prevention of migraine attacks. - safety and effectiveness of naratriptan tablets have not been established for cluster headache. naratriptan tablets are contraindicated in patients with: - ischemic coronary artery disease (cad) (angina pectoris, history of myocardial infarction, or documented silent ischemia) or coronary artery vasospasm, including prinzmetal's angina [see warnings and precautions (5.1) ] - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway d